Skip to main content

Table 3 Antimicrobial sensitivity patterns among different E. coli types

From: Prevalence, phylogeny, and antimicrobial resistance of Escherichia coli pathotypes isolated from children less than 5 years old with community acquired- diarrhea in Upper Egypt

Antibiotics E coli types
EAEC
N = 31
t EPEC
N = 19
a EPEC
N = 11
Co-infection
N = 5
Total
N = 66
MEM Sensitive 27 (87.10%) 16 (84.21%) 10 (90.9%) 5 (100%) 58 (87.9%)
Intermediate 2 (6.45%) 0 (0.0%) 0(0.0%) 0 (0.0%) 2 (3%)
Resistant 2 (6.45%) 3 (15.79%) 1 (9.09%) 0 (0.0%) 6 (9.1%)
CAZ Sensitive 4 (12.90%) 3 (15.79%) 0 (0.0%) 0 (0.0%) 7 (10.6%)
Intermediate 6 (19.36%) 4 (21.05%) 1 (9.09%) 0 (0.0%) 11 (16.6%)
Resistant 21 (67.74%) 12 (63.16%) 10 (90.9%) 5 (100.0%) 48 (72.7%)
CRO Sensitive 7 (22.58%) 4 (21.05%) 0 (0.0%) 1 (20.0%) 12 (18.2%)
Intermediate 8 (25.81%) 2 (10.53%) 0 (0.0%) 0 (0.0%) 10 (15.2%)
Resistant 16 (51.61%) 13 (68.42%) 11 (100.0%) 4 (80.0%) 44 (66.6%)
FOX Sensitive 21 (67.74%) 10 (52.63%) 4 (36.36%) 4 (80.0%) 39 (59.1%)
Intermediate 4 (12.91%) 5 (26.32%) 3 (27.28%) 0 (00.0%) 12 (18.2%)
Resistant 6 (19.35%) 4 (21.05%) 4 (36.36%) 1 (20.0%) 15 (22.7%)
AK Sensitive 13 (41.93%) 10 (52.63%) 8 (72.73%) 4 (80.0%) 35 (53%)
Intermediate 8 (25.81%) 5 (26.32%) 1 (9.09%) 1 (20.0%) 15 (22.7%)
Resistant 10 (32.26%) 4 (21.05%) 2 (18.18%) 0 (00.0%) 16 (24.2%)
SXT Sensitive 7 (22.58%) 6 (31.58%) 0 (00.0%) 0 (0.0%) 13 (19.7%)
Intermediate 3 (9.68%) 4 (21.05%) 4 (36.36%) 1 (20.0%) 12 (18.2%)
Resistant 21 (67.74%) 9 (47.37%) 7 (63.64%) 4 (80.0%) 41 (62.1%)
TE Sensitive 3 (9.68%) 5 (26.32%) 0 (00.0%) 4 (80.0%) 12 (19.2%)
Intermediate 0 (00.0%) 3 (15.79%) 0 (00.0%) 0 (00.0%) 3 (4.5%)
Resistant 28 (90.32%) 11(57.89%) 11 (100.0%) 1 (20.0%) 51 (77.3%)
AMC Sensitive 5 (16.13%) 2 (10.53%) 1 (9.09%) 0 (00.0%) 8 (12.1%)
Intermediate 1 (3.22%) 5 (26.32%) 7 (63.64%) 5 (100.0%) 18 (27.3%)
Resistant 25 (80.65%) 12 (63.15%) 3 (27.27%) 0 (00.0%) 40 (60.6%)
  1. sulfamethoxazole -Trimethoprim, (SXT); Amikacin (AK); Cefoxitin (FOX); Ceftriaxone (CRO); Meropenem (MEM); Tetracycline (TE); Ceftazidime (CAZ); Amoxicillin-clavulanate (AMC)